TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Design & Evaluation of a Medication Therapy Management Program to Improve Patient Safety in Medicare Beneficiaries
Brief Summary: The purpose of this study is to determine if a medication therapy management program designed to reconcile a patient's medications and identify and resolve drug related problems can reduce adverse drug events and other measures of safety and improve patient satisfaction.


Options:
A: Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Basic medication therapy management; Type: EXPERIMENTAL; Interventions: Behavioral: Basic medication therapy management | Arm Label: Enhanced medication therapy management; Type: EXPERIMENTAL; Interventions: Behavioral: Enhanced medication therapy management | Intervention Type: BEHAVIORAL; Name: Basic medication therapy management; Assigned to Arm(s): Basic medication therapy management | Intervention Type: BEHAVIORAL; Name: Enhanced medication therapy management; Assigned to Arm(s): Enhanced medication therapy management
B: Intervention Type: BEHAVIORAL; Name: Self-Help Intervention Program-High Blood Pressure; Assigned to Arm(s): N/A
C: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: oral education & written tips for remembering medications, Device: pill box, Device: pocket medication card, Behavioral: sharing information with community pharmacist, Behavioral: Medication use evaluations by community pharmacist, Behavioral: informing physician if patient has stopped a medication, Behavioral: Routine discharge counseling, Other: Letter to physician/discharge summary | Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Routine discharge counseling, Other: Letter to physician/discharge summary | Intervention Type: BEHAVIORAL; Name: oral education & written tips for remembering medications; Assigned to Arm(s): Intervention | Intervention Type: DEVICE; Name: pill box; Assigned to Arm(s): Intervention | Intervention Type: DEVICE; Name: pocket medication card; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: sharing information with community pharmacist; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Medication use evaluations by community pharmacist; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: informing physician if patient has stopped a medication; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Routine discharge counseling; Assigned to Arm(s): Intervention, Usual Care | Intervention Type: OTHER; Name: Letter to physician/discharge summary; Assigned to Arm(s): Intervention, Usual Care
D: Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Pharmacist Intervention for Low-Literacy in Cardiovascular Disease | Intervention Type: BEHAVIORAL; Name: Pharmacist Intervention for Low-Literacy in Cardiovascular Disease; Assigned to Arm(s): 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Design & Evaluation of a Medication Therapy Management Program to Improve Patient Safety in Medicare Beneficiaries
Brief Summary: The purpose of this study is to determine if a medication therapy management program designed to reconcile a patient's medications and identify and resolve drug related problems can reduce adverse drug events and other measures of safety and improve patient satisfaction.


Options:
A: Arm Label: Psychoeducative intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Psychoeducative intervention | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Psychoeducative intervention; Assigned to Arm(s): Psychoeducative intervention
B: Arm Label: with mobile phone assistance; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Mobile-phone-based Home Exercise Training Program, Behavioral: Home Exercise Training Program | Arm Label: with free walk; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Home Exercise Training Program | Intervention Type: BEHAVIORAL; Name: Mobile-phone-based Home Exercise Training Program; Assigned to Arm(s): with mobile phone assistance | Intervention Type: BEHAVIORAL; Name: Home Exercise Training Program; Assigned to Arm(s): with free walk, with mobile phone assistance
C: Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Basic medication therapy management; Type: EXPERIMENTAL; Interventions: Behavioral: Basic medication therapy management | Arm Label: Enhanced medication therapy management; Type: EXPERIMENTAL; Interventions: Behavioral: Enhanced medication therapy management | Intervention Type: BEHAVIORAL; Name: Basic medication therapy management; Assigned to Arm(s): Basic medication therapy management | Intervention Type: BEHAVIORAL; Name: Enhanced medication therapy management; Assigned to Arm(s): Enhanced medication therapy management
D: Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Counseling and Nicotine replacement (CN) | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Behavioral: Counseling, Nicotine replacement and Bupropion (CNB) | Intervention Type: BEHAVIORAL; Name: Counseling and Nicotine replacement (CN); Assigned to Arm(s): 2 | Intervention Type: BEHAVIORAL; Name: Counseling, Nicotine replacement and Bupropion (CNB); Assigned to Arm(s): 3

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Design & Evaluation of a Medication Therapy Management Program to Improve Patient Safety in Medicare Beneficiaries
Brief Summary: The purpose of this study is to determine if a medication therapy management program designed to reconcile a patient's medications and identify and resolve drug related problems can reduce adverse drug events and other measures of safety and improve patient satisfaction.


Options:
A: Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Basic medication therapy management; Type: EXPERIMENTAL; Interventions: Behavioral: Basic medication therapy management | Arm Label: Enhanced medication therapy management; Type: EXPERIMENTAL; Interventions: Behavioral: Enhanced medication therapy management | Intervention Type: BEHAVIORAL; Name: Basic medication therapy management; Assigned to Arm(s): Basic medication therapy management | Intervention Type: BEHAVIORAL; Name: Enhanced medication therapy management; Assigned to Arm(s): Enhanced medication therapy management
B: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention arm; Type: EXPERIMENTAL; Interventions: Other: Optimization strategy (complex intervention) | Intervention Type: OTHER; Name: Optimization strategy (complex intervention); Assigned to Arm(s): Intervention arm
C: Arm Label: Pharmacist Intervention; Type: EXPERIMENTAL; Interventions: Procedure: Pharmacist Intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Pharmacist Intervention; Assigned to Arm(s): Pharmacist Intervention
D: Arm Label: Intervention; Type: OTHER; Interventions: Other: E-learning | Arm Label: Control; Type: OTHER; Interventions: Other: E-learning | Intervention Type: OTHER; Name: E-learning; Assigned to Arm(s): Control, Intervention

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Transdisciplinary Studies of CBT for Anxiety in Youth
Brief Summary: The purpose of this study is to investigate neurobehavioral, affective, and social processes that may influence and predict treatment response in pediatric anxiety disorders.


Options:
A: Arm Label: Cognitive Behavioral Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive-behavioral therapy | Arm Label: Waitlist; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive-behavioral therapy; Assigned to Arm(s): Cognitive Behavioral Therapy
B: Arm Label: CBT; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Coping Cat cognitive-behavioral therapy for anxious youth | Arm Label: Waitlist Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Coping Cat cognitive-behavioral therapy for anxious youth; Assigned to Arm(s): CBT
C: Arm Label: Social Effectiveness Therapy for Children; Type: EXPERIMENTAL; Interventions: Behavioral: Social Effectiveness Therapy for Children (SET-C) | Arm Label: Fluoxetine; Type: EXPERIMENTAL; Interventions: Drug: Fluoxetine | Arm Label: Pill placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Pill Placebo | Intervention Type: BEHAVIORAL; Name: Social Effectiveness Therapy for Children (SET-C); Assigned to Arm(s): Social Effectiveness Therapy for Children | Intervention Type: DRUG; Name: Fluoxetine; Assigned to Arm(s): Fluoxetine | Intervention Type: DRUG; Name: Pill Placebo; Assigned to Arm(s): Pill placebo
D: Arm Label: 1. Cognitive Behavioral Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy | Arm Label: 2. Client Centered Therapy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Client Centered Therapy | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): 1. Cognitive Behavioral Therapy | Intervention Type: BEHAVIORAL; Name: Client Centered Therapy; Assigned to Arm(s): 2. Client Centered Therapy

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Retrospective Cohort of the Avaulta Vaginal Mesh Procedure as a Treatment of Pelvic Organ Prolapse
Brief Summary: This study is a 1 year review of all patients who had surgery to correct pelvic organ prolapse (i.e. cystocele, rectocele, enterocele) using the Avaulta synthetic mesh kit.


Options:
A: Arm Label: SIS Mesh (Cook Medical); Type: EXPERIMENTAL; Interventions: Device: SIS mesh (Cook Medical), Procedure: Anterior prolapse repair | Arm Label: No-mesh; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Anterior prolapse repair | Intervention Type: DEVICE; Name: SIS mesh (Cook Medical); Assigned to Arm(s): SIS Mesh (Cook Medical) | Intervention Type: PROCEDURE; Name: Anterior prolapse repair; Assigned to Arm(s): No-mesh, SIS Mesh (Cook Medical)
B: N/A
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Anterior colporrhaphy | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Procedure: Anterior PROLIFT | Intervention Type: PROCEDURE; Name: Anterior colporrhaphy; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Anterior PROLIFT; Assigned to Arm(s): 2
D: Arm Label: Anterior colporrhaphy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: anterior vaginal repair (colporrhaphy), Procedure: abdominal paravaginal defect repair | Arm Label: Paravaginal defect repair; Type: ACTIVE_COMPARATOR; Interventions: Procedure: anterior vaginal repair (colporrhaphy), Procedure: abdominal paravaginal defect repair | Intervention Type: PROCEDURE; Name: anterior vaginal repair (colporrhaphy); Assigned to Arm(s): Anterior colporrhaphy, Paravaginal defect repair | Intervention Type: PROCEDURE; Name: abdominal paravaginal defect repair; Assigned to Arm(s): Anterior colporrhaphy, Paravaginal defect repair

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Retrospective Cohort of the Avaulta Vaginal Mesh Procedure as a Treatment of Pelvic Organ Prolapse
Brief Summary: This study is a 1 year review of all patients who had surgery to correct pelvic organ prolapse (i.e. cystocele, rectocele, enterocele) using the Avaulta synthetic mesh kit.


Options:
A: Arm Label: Mesh surgery; Type: EXPERIMENTAL; Interventions: Device: Tensionfree vaginal mesh kit (Prolift) | Arm Label: Conventional vaginal surgery; Type: ACTIVE_COMPARATOR; Interventions: Procedure: classic vaginal prolapse surgery (fascia plication) | Intervention Type: DEVICE; Name: Tensionfree vaginal mesh kit (Prolift); Assigned to Arm(s): Mesh surgery | Intervention Type: PROCEDURE; Name: classic vaginal prolapse surgery (fascia plication); Assigned to Arm(s): Conventional vaginal surgery
B: Intervention Type: DEVICE; Name: Low-weight prolypropylene mesh; Assigned to Arm(s): N/A
C: N/A
D: Arm Label: Anterior Colporrhaphy (sutured repair); Type: PLACEBO_COMPARATOR; Interventions: Procedure: sutured anterior vaginal prolapse repair | Arm Label: Perigee (grafted repair); Type: ACTIVE_COMPARATOR; Interventions: Device: grafted anterior prolapse repair | Intervention Type: DEVICE; Name: grafted anterior prolapse repair; Assigned to Arm(s): Perigee (grafted repair) | Intervention Type: PROCEDURE; Name: sutured anterior vaginal prolapse repair; Assigned to Arm(s): Anterior Colporrhaphy (sutured repair)

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Retrospective Cohort of the Avaulta Vaginal Mesh Procedure as a Treatment of Pelvic Organ Prolapse
Brief Summary: This study is a 1 year review of all patients who had surgery to correct pelvic organ prolapse (i.e. cystocele, rectocele, enterocele) using the Avaulta synthetic mesh kit.


Options:
A: N/A
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Avaulta (surgical procedure using a mesh implant) | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Conventional surgery (anterior repair) | Intervention Type: PROCEDURE; Name: Avaulta (surgical procedure using a mesh implant); Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Conventional surgery (anterior repair); Assigned to Arm(s): 2
C: Arm Label: Abdominal Sacral Colpopexy with no Burch colposuspension; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Abdominal Sacral Colpopexy with Burch Colposuspension; Type: EXPERIMENTAL; Interventions: Procedure: Burch urethropexy at time of sacrocolpopexy | Intervention Type: PROCEDURE; Name: Burch urethropexy at time of sacrocolpopexy; Assigned to Arm(s): Abdominal Sacral Colpopexy with Burch Colposuspension
D: Arm Label: Anterior colporrhaphy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: anterior vaginal repair (colporrhaphy), Procedure: abdominal paravaginal defect repair | Arm Label: Paravaginal defect repair; Type: ACTIVE_COMPARATOR; Interventions: Procedure: anterior vaginal repair (colporrhaphy), Procedure: abdominal paravaginal defect repair | Intervention Type: PROCEDURE; Name: anterior vaginal repair (colporrhaphy); Assigned to Arm(s): Anterior colporrhaphy, Paravaginal defect repair | Intervention Type: PROCEDURE; Name: abdominal paravaginal defect repair; Assigned to Arm(s): Anterior colporrhaphy, Paravaginal defect repair

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Clinical Evaluation of the I-ZIP® Ocular Bandage as a Protective Ocular Bandage in Subjects Undergoing Clear Corneal Cataract Surgery With IOL Implantation: A Pivotal Study
Brief Summary: To evaluate the safety and performance of the I-ZIP Ocular Bandage in subjects undergoing uneventful unilateral clear corneal phacoemulsification with foldable monofocal intraocular lens (IOL) implantation compared with the Oasis 24-hour Soft Shield Collagen Corneal Shield (Oasis Medical, Inc. Glendora, California) for providing ocular protection and relief of pain or discomfort in the acute post-operative period.


Options:
A: Arm Label: Control group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Pressure dressing | Arm Label: Experimental group; Type: EXPERIMENTAL; Interventions: Procedure: Normal dressing | Intervention Type: PROCEDURE; Name: Normal dressing; Assigned to Arm(s): Experimental group | Intervention Type: PROCEDURE; Name: Pressure dressing; Assigned to Arm(s): Control group
B: Arm Label: Silver Eluting Dressing; Type: EXPERIMENTAL; Interventions: Other: Surgical dressing | Arm Label: Standard Guaze; Type: ACTIVE_COMPARATOR; Interventions: Other: Surgical dressing | Intervention Type: OTHER; Name: Surgical dressing; Assigned to Arm(s): Silver Eluting Dressing, Standard Guaze
C: Arm Label: Mepore Self-adhesive absorbent dressing; Type: ACTIVE_COMPARATOR; Interventions: Device: Mepore Self-adhesive absorbent dressing | Arm Label: AQUAGEL Ag Hydrofiber Wound Dressing; Type: EXPERIMENTAL; Interventions: Device: AQUAGEL Ag Hydrofiber Wound Dressing | Intervention Type: DEVICE; Name: AQUAGEL Ag Hydrofiber Wound Dressing; Assigned to Arm(s): AQUAGEL Ag Hydrofiber Wound Dressing | Intervention Type: DEVICE; Name: Mepore Self-adhesive absorbent dressing; Assigned to Arm(s): Mepore Self-adhesive absorbent dressing
D: Arm Label: I-ZIP Ocular Bandage; Type: EXPERIMENTAL; Interventions: Device: I-ZIP Ocular Bandage | Arm Label: Oasis 24 hour Soft Shield Collagen Corneal Shield; Type: ACTIVE_COMPARATOR; Interventions: Device: Oasis 24 Hour Soft Shield Collagen Corneal Shield | Intervention Type: DEVICE; Name: I-ZIP Ocular Bandage; Assigned to Arm(s): I-ZIP Ocular Bandage | Intervention Type: DEVICE; Name: Oasis 24 Hour Soft Shield Collagen Corneal Shield; Assigned to Arm(s): Oasis 24 hour Soft Shield Collagen Corneal Shield

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Lenalidomide (Revlimid®) as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia Following Second-Line Therapy (The Continuum Trial)
Brief Summary: The purpose of this study is to determine if lenalidomide (Revlimid®) is safe and effective as a maintenance therapy at improving further the quality of the response you achieved with your last therapy and at prolonging the duration of your response. This study will compare the effects (good and bad) of lenalidomide with the dummy drug.


Options:
A: Arm Label: Rituximab + PCI-32765; Type: EXPERIMENTAL; Interventions: Drug: Rituximab, Drug: PCI-32765 | Intervention Type: DRUG; Name: Rituximab; Assigned to Arm(s): Rituximab + PCI-32765 | Intervention Type: DRUG; Name: PCI-32765; Assigned to Arm(s): Rituximab + PCI-32765
B: Arm Label: Idelalisib+bendamustine+rituximab; Type: EXPERIMENTAL; Interventions: Drug: Idelalisib, Drug: Rituximab, Drug: Bendamustine | Arm Label: Placebo to match idelalisib+bendamustine+rituximab; Type: PLACEBO_COMPARATOR; Interventions: Drug: Rituximab, Drug: Bendamustine, Drug: Placebo to match idelalisib | Intervention Type: DRUG; Name: Idelalisib; Assigned to Arm(s): Idelalisib+bendamustine+rituximab | Intervention Type: DRUG; Name: Rituximab; Assigned to Arm(s): Idelalisib+bendamustine+rituximab, Placebo to match idelalisib+bendamustine+rituximab | Intervention Type: DRUG; Name: Bendamustine; Assigned to Arm(s): Idelalisib+bendamustine+rituximab, Placebo to match idelalisib+bendamustine+rituximab | Intervention Type: DRUG; Name: Placebo to match idelalisib; Assigned to Arm(s): Placebo to match idelalisib+bendamustine+rituximab
C: Arm Label: Experimental: 1; Type: EXPERIMENTAL; Interventions: Drug: Lenalidomide | Arm Label: Placebo Comparator: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Lenalidomide; Assigned to Arm(s): Experimental: 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo Comparator: 2
D: Arm Label: Treatment (alemtuzumab, rituximab, fludarabine phosphate); Type: EXPERIMENTAL; Interventions: Biological: alemtuzumab, Biological: rituximab, Drug: fludarabine phosphate | Intervention Type: BIOLOGICAL; Name: alemtuzumab; Assigned to Arm(s): Treatment (alemtuzumab, rituximab, fludarabine phosphate) | Intervention Type: BIOLOGICAL; Name: rituximab; Assigned to Arm(s): Treatment (alemtuzumab, rituximab, fludarabine phosphate) | Intervention Type: DRUG; Name: fludarabine phosphate; Assigned to Arm(s): Treatment (alemtuzumab, rituximab, fludarabine phosphate)

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: a Randomized Controlled Trial Evaluating the Effectiveness and the Safety of Surgical Masks Wared by the Index Patient for Preventing Secondary Transmission of Influenza A in Households
Brief Summary: This work aims to measure the effectiveness of face mask worn by a patient with flu to avoid transmission to other persons in the household.


Options:
A: Arm Label: N95 Respirator; Type: ACTIVE_COMPARATOR; Interventions: Device: N95 Respirator | Arm Label: Medical/surgical mask; Type: ACTIVE_COMPARATOR; Interventions: Device: Medical/surgical mask | Intervention Type: DEVICE; Name: N95 Respirator; Assigned to Arm(s): N95 Respirator | Intervention Type: DEVICE; Name: Medical/surgical mask; Assigned to Arm(s): Medical/surgical mask
B: Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Device: control | Arm Label: 1; Type: EXPERIMENTAL; Interventions: Device: Face mask | Intervention Type: DEVICE; Name: control; Assigned to Arm(s): 2 | Intervention Type: DEVICE; Name: Face mask; Assigned to Arm(s): 1
C: Arm Label: Green tea; Type: EXPERIMENTAL; Interventions: Dietary Supplement: green tea | Arm Label: water; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: green tea | Intervention Type: DIETARY_SUPPLEMENT; Name: green tea; Assigned to Arm(s): Green tea, water
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Other: health education | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: hand hygiene | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Behavioral: hand hygiene, Device: face masks | Intervention Type: BEHAVIORAL; Name: hand hygiene; Assigned to Arm(s): 2, 3 | Intervention Type: OTHER; Name: health education; Assigned to Arm(s): 1 | Intervention Type: DEVICE; Name: face masks; Assigned to Arm(s): 3

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: a Randomized Controlled Trial Evaluating the Effectiveness and the Safety of Surgical Masks Wared by the Index Patient for Preventing Secondary Transmission of Influenza A in Households
Brief Summary: This work aims to measure the effectiveness of face mask worn by a patient with flu to avoid transmission to other persons in the household.


Options:
A: Arm Label: Chlorhexidine; Type: ACTIVE_COMPARATOR; Interventions: Other: Oral care with 0,12% Chlorhexidine | Arm Label: Placebo Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Oral care with 0,12% Chlorhexidine; Assigned to Arm(s): Chlorhexidine
B: Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Device: control | Arm Label: 1; Type: EXPERIMENTAL; Interventions: Device: Face mask | Intervention Type: DEVICE; Name: control; Assigned to Arm(s): 2 | Intervention Type: DEVICE; Name: Face mask; Assigned to Arm(s): 1
C: Arm Label: State of the Art strategy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: state-of-the art strategy and extented strategy | Arm Label: extended strategy; Type: EXPERIMENTAL; Interventions: Behavioral: state-of-the art strategy and extented strategy | Intervention Type: BEHAVIORAL; Name: state-of-the art strategy and extented strategy; Assigned to Arm(s): State of the Art strategy, extended strategy
D: Arm Label: Normal recommendations, no mask; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Normal recommendations AND mask; Type: EXPERIMENTAL; Interventions: Other: Surgical facial mask | Intervention Type: OTHER; Name: Surgical facial mask; Assigned to Arm(s): Normal recommendations AND mask

Answer: B